LPL Financial’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,852
Closed -$12.3K 6119
2025
Q4
$12.3K Buy
1,852
+1
+0.1% +$11 ﹤0.01% 5842
2025
Q3
$23.9K Hold
1,851
﹤0.01% 5721
2025
Q2
$33.3K Hold
1,851
﹤0.01% 5416
2025
Q1
$40.1K Buy
+1,851
New +$38.4K ﹤0.01% 5173
2023
Q4
Sell
-216
Closed -$28.6K 4873
2023
Q3
$28.6K Sell
216
-7
-3% -$1.08K ﹤0.01% 4579
2023
Q2
$40.8K Buy
223
+51
+30% +$10.2K ﹤0.01% 4445
2023
Q1
$28.9K Hold
172
﹤0.01% 4381
2022
Q4
$37.2K Sell
172
-22
-11% -$8.31K ﹤0.01% 4308
2022
Q3
$75K Buy
194
+83
+75% +$47K ﹤0.01% 4165
2022
Q2
$47K Buy
111
+10
+10% +$4.83K ﹤0.01% 4245
2022
Q1
$60K Buy
101
+31
+44% +$23K ﹤0.01% 4037
2021
Q4
$77K Buy
+70
New +$152K ﹤0.01% 4176

Other funds holding PAVM

LPL Financial's PAVM Position: Q1 2026 in Review

LPL Financial sold out of PAVmed (PAVM) in Q1 2026, closing a stake of 1,852 shares — an estimated $12.3K sold.

LPL Financial first reported a position in PAVM in Q4 2021 and held it in 12 quarters. The position peaked at $77K in Q4 2021. 20 funds tracked by Wall St. Rank hold PAVM as of Q1 2026.

  • LPL Financial reported no remaining PAVmed position as of Q1 2026 after selling out during the quarter.
  • LPL Financial sold 1,852 PAVmed shares in Q1 2026, an estimated $12.3K.
  • LPL Financial first reported a position in PAVmed in Q4 2021 and held it in 12 quarters.
  • LPL Financial's PAVmed position peaked at $77K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held PAVmed as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.